for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Johnson & Johnson

JNJ.N

Latest Trade

131.20USD

Change

-0.15(-0.11%)

Volume

599,457

Today's Range

130.73

 - 

131.48

52 Week Range

122.00

 - 

148.97

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
131.35
Open
131.04
Volume
599,457
3M AVG Volume
164.07
Today's High
131.48
Today's Low
130.73
52 Week High
148.97
52 Week Low
122.00
Shares Out (MIL)
2,631.87
Market Cap (MIL)
347,354.50
Forward P/E
15.21
Dividend (Yield %)
2.88

Next Event

Dividend For JNJ.N - 0.9500 USD

Latest Developments

More

TREMFYA (guselkumab), IL-23 p19 Subunit Inhibitor, Meets Primary Endpoints Of Superior ACR20 Responses Versus Placebo At Week 24 In Phase 3 Psoriatic Arthritis Studies

Janssen Announces Submission Of Supplemental NDA To U.S. FDA Seeking Approval Of Imbruvica (Ibrutinib) In Combination With Rituximab

Janssen Announces Health Canada Approval Of Imbruvica In Combination With Obinutuzumab

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Industry

Biotechnology & Drugs

Contact Info

1 Johnson And Johnson Plz

+1.732.5242455

https://www.jnj.com/

Executive Leadership

Alex Gorsky

Chairman of the Board, Chief Executive Officer

Paulus A. Stoffels

Vice Chairman- Executive Committee, Chief Scientific Officer

Joaquin Boix Duato

Vice Chairman - Executive Committee

Joseph J. Wolk

Chief Financial Officer, Executive Vice President

Peter M. Fasolo

Chief Human Resource Officer, Executive Vice President

Key Stats

2.11 mean rating - 18 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

71.9K

2017

76.5K

2018

81.6K

2019(E)

82.1K
EPS (USD)

2016

6.730

2017

7.300

2018

8.180

2019(E)

8.674
Price To Earnings (TTM)
25.16
Price To Sales (TTM)
4.25
Price To Book (MRQ)
5.97
Price To Cash Flow (TTM)
16.48
Total Debt To Equity (MRQ)
49.34
LT Debt To Equity (MRQ)
46.24
Return on Investment (TTM)
11.38
Return on Equity (TTM)
9.09

Latest News

Latest News

Johnson & Johnson files for European approval of Ebola vaccine

Johnson & Johnson <JNJ.N> said on Thursday it had filed for an approval from European regulators for its two-dose experimental vaccine to protect against Ebola, less than a month after the agency recommended approval of Merck & Co Inc's <MRK.N> vaccine.

Johnson & Johnson files for European approval of Ebola vaccine

Johnson & Johnson said on Thursday it had filed for European approval for its experimental vaccine regimen to protect against a strain of Ebola virus that most commonly causes outbreaks of the deadly disease.

Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder

Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

Exclusive: J&J's own expert, working for FDA, found asbestos in Baby Powder

Ever since Johnson & Johnson <JNJ.N> disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

J&J says new tests find no asbestos in same baby powder bottle that sparked recall

Johnson & Johnson said on Tuesday that 15 new tests found no asbestos in a bottle of baby powder that the U.S. Food and Drug Administration says tested positive for trace amounts of asbestos, a finding the agency stands by.

Johnson & Johnson says new tests find no asbestos in FDA-tested baby powder

Johnson & Johnson said on Tuesday that 15 new tests from the same bottle of its baby powder previously tested by the U.S. Food and Drug Administration found no asbestos.

Justice Department issues grand jury subpoenas in J&J opioid probe: filing

Johnson & Johnson <JNJ.N> received grand jury subpoenas in August from the U.S. attorney's office for the Eastern District of New York related to its opioid medication policies, the company said in a regulatory filing on Monday.

J&J CEO testified Baby Powder was safe 13 days before FDA bombshell

Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive Alex Gorsky earlier this month insisted that the company’s iconic brand was safe.

Walgreens, Target remove all 22-ounce J&J baby powder from their shelves

Walgreens Boots Alliance Inc and Target Corp on Friday became the latest retailers to remove all 22-ounce bottles of Johnson & Johnson baby powder from their stores, after the healthcare conglomerate recalled some bottles because of possible asbestos contamination.

Big U.S. retailers pull 22-ounce J&J baby powder off shelves after recall

Four major U.S. retailers, including Walmart <WMT.N> and Target Corp <TGT.N>, are removing all 22-ounce bottles of Johnson & Johnson's <JNJ.N> baby powder from their stores, following the healthcare conglomerate's recall last week of some bottles due to possible asbestos...

Target removes all 22-ounce J&J baby powder from its shelves

Target Corp <TGT.N> on Friday became the latest retailer to remove all 22-ounce bottles of Johnson & Johnson <JNJ.N> baby powder from its stores, after the healthcare conglomerate recalled some bottles because of possible asbestos contamination.

Target removes all 22-ounce J&J baby powder from its shelves

Target Corp on Friday became the latest retailer to remove all 22-ounce bottles of Johnson & Johnson baby powder from its stores, after the healthcare conglomerate recalled some bottles because of possible asbestos contamination.

Walmart pulls 22-ounce J&J baby powder from shelves - CNBC

Walmart Inc has removed and blocked sales of Johnson & Johnson's 22-ounce baby powder bottles from its stores, CNBC reported on Thursday, making it the third large retailer to pull the product.

Walmart pulls 22-ounce J&J baby powder from shelves - CNBC

Walmart Inc <WMT.N> has removed and blocked sales of Johnson & Johnson's <JNJ.N> 22-ounce baby powder bottles from its stores, CNBC reported https://www.cnbc.com/2019/10/24/cvs-pulls-all-jj-22-ounce-baby-powder-from-shelves-after-fda-finds-sub-trace-levels-of-asbestos.html...

Walmart pulls 22-ounce J&J baby powder from shelves - CNBC

Walmart Inc has removed and blocked sales of Johnson & Johnson's 22-ounce baby powder bottles from its stores, CNBC reported https://www.cnbc.com/2019/10/24/cvs-pulls-all-jj-22-ounce-baby-powder-from-shelves-after-fda-finds-sub-trace-levels-of-asbestos.html on Thursday,...

CVS pulls out 22 ounce J&J baby powder from stores

Pharmacy retailer CVS Health Corp said on Thursday it is pulling out 22 ounce bottles of Johnson & Johnson's baby powder from its stores as a precautionary measure.

J&J slashes third-quarter profit by $3 billion over proposed opioid deal

Johnson & Johnson <JNJ.N> on Wednesday lowered its previously reported third-quarter profit by $3 billion (£2.33 billion) to account for a proposed opioid settlement payment.

J&J says proposed opioid settlement to lower reported Q3 profit by $3 bln

Johnson & Johnson on Wednesday lowered its previously reported profit for the third quarter to $1.8 billion from $4.8 billion to account for a proposed opioid settlement payment.

FDA alerts consumers of J&J baby powder recall, says it stands by tests

The U.S. Food & Drug Administration said on Friday that it found that a sample from one lot of Johnson & Johnson's baby powder contained chrysotile fibers, a type of asbestos, confirming test results the company disclosed earlier on Friday.

J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample

Johnson & Johnson said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators found trace amounts of asbestos in samples taken from a bottle purchased online.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up